Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ
Watchlist
Price: 15.01 EUR Market Closed
Market Cap: €312.9m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+17%
5Y
+60%
10Y
+136%
Liabilities
+
3Y
+18%
5Y
+63%
10Y
+133%
Equity
+
3Y
+16%
5Y
+58%
10Y
+139%

Balance Sheet Decomposition
Eckert & Ziegler Strahlen und Medizintechnik AG

Balance Sheet
Eckert & Ziegler Strahlen und Medizintechnik AG

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
4
6
9
6
5
5
4
7
44
29
32
31
29
22
31
37
58
54
79
87
94
83
68
118
Cash Equivalents
4
6
9
6
5
5
4
7
44
29
32
31
29
22
31
37
58
54
79
87
94
83
68
118
Short-Term Investments
4
2
1
2
2
1
1
0
0
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
Total Receivables
5
4
4
7
10
11
12
14
16
17
18
23
20
23
21
23
24
28
29
31
35
46
54
60
Accounts Receivables
5
4
4
7
10
11
12
14
16
17
18
20
20
23
21
23
24
28
29
28
32
40
47
49
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
3
3
6
7
10
Inventory
5
4
3
6
6
6
8
9
13
13
14
16
18
24
25
25
27
29
31
34
37
39
40
44
Other Current Assets
1
1
2
2
1
1
2
4
6
3
5
3
5
7
10
9
7
11
7
19
10
6
71
3
Total Current Assets
18
18
18
21
24
24
27
34
79
62
69
73
73
78
89
94
116
122
147
173
178
174
234
225
PP&E Net
20
18
15
13
19
16
18
24
27
28
29
31
34
36
36
38
34
37
60
58
81
112
112
132
PP&E Gross
20
18
15
13
19
16
18
24
27
28
29
31
34
36
36
38
34
37
60
58
81
112
112
132
Accumulated Depreciation
11
13
16
19
19
19
20
25
29
34
39
41
44
45
54
59
53
58
63
53
58
66
74
83
Intangible Assets
6
5
4
5
7
7
8
12
15
11
14
15
18
17
14
13
10
11
10
6
28
54
13
13
Goodwill
8
7
6
7
12
11
10
27
28
30
31
31
35
38
40
40
41
42
42
32
34
43
36
37
Note Receivable
1
1
0
0
0
0
0
0
0
0
0
2
3
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
1
0
0
0
1
5
3
3
3
4
4
7
15
14
32
22
Other Long-Term Assets
0
2
2
3
6
6
5
2
13
13
11
13
17
12
15
12
13
14
12
13
12
10
13
14
Other Assets
8
7
6
7
12
11
10
27
28
30
31
31
35
38
40
40
41
42
42
32
34
43
36
37
Total Assets
53
N/A
50
-6%
46
-8%
49
+7%
67
+37%
64
-4%
68
+5%
99
+46%
162
+64%
145
-11%
154
+7%
164
+7%
179
+9%
187
+5%
197
+5%
199
+1%
217
+9%
229
+6%
274
+20%
289
+6%
348
+20%
407
+17%
439
+8%
442
+1%
Liabilities
Accounts Payable
2
1
1
2
4
4
4
4
4
4
5
8
8
8
8
6
5
6
4
5
6
8
6
9
Accrued Liabilities
2
2
2
3
0
0
0
9
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
0
0
3
3
8
8
6
6
5
6
5
11
11
8
2
0
3
3
10
3
9
9
Other Current Liabilities
3
3
3
2
7
7
9
5
11
19
18
21
19
23
21
20
28
28
36
42
45
46
69
45
Total Current Liabilities
8
7
6
7
14
14
21
26
34
29
29
34
32
43
39
34
34
34
44
49
60
57
84
72
Long-Term Debt
4
3
4
2
9
7
4
11
14
16
13
10
18
7
5
4
0
0
17
18
17
47
47
46
Deferred Income Tax
1
1
1
1
3
2
1
1
2
1
2
2
0
3
4
3
2
2
3
2
2
5
1
2
Minority Interest
0
0
0
0
0
0
0
2
10
5
6
6
7
6
5
5
5
1
1
1
5
2
2
2
Other Liabilities
5
6
6
6
6
5
5
18
25
26
29
32
39
40
44
48
63
69
71
74
76
85
83
97
Total Liabilities
17
N/A
17
-2%
17
+1%
16
-4%
32
+97%
28
-12%
32
+11%
58
+84%
86
+48%
76
-11%
78
+3%
84
+7%
95
+14%
99
+4%
97
-2%
94
-3%
105
+11%
106
+2%
136
+28%
144
+6%
160
+11%
195
+22%
217
+11%
219
+1%
Equity
Common Stock
3
3
3
3
3
3
3
3
5
5
5
5
5
5
5
5
5
5
5
21
21
21
21
21
Retained Earnings
6
3
0
3
3
3
4
8
19
10
17
25
29
32
40
45
56
70
85
81
106
123
139
128
Additional Paid In Capital
27
27
27
28
29
30
30
30
53
54
54
54
54
54
54
54
54
54
54
54
66
67
67
69
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
4
2
2
1
Treasury Stock
0
0
1
1
0
0
0
0
1
0
0
0
0
0
0
0
0
6
6
6
4
4
3
3
Other Equity
0
0
0
0
0
0
0
0
0
0
0
3
4
2
1
1
3
0
1
1
1
6
0
10
Total Equity
36
N/A
33
-8%
29
-12%
33
+14%
35
+7%
36
+3%
36
+1%
41
+13%
76
+87%
68
-11%
76
+11%
81
+6%
84
+3%
89
+6%
100
+13%
105
+6%
112
+7%
123
+9%
138
+13%
145
+5%
187
+29%
212
+13%
222
+5%
223
+1%
Total Liabilities & Equity
53
N/A
50
-6%
46
-8%
49
+7%
67
+37%
64
-4%
68
+5%
99
+46%
162
+64%
145
-11%
154
+7%
164
+7%
179
+9%
187
+5%
197
+5%
199
+1%
217
+9%
229
+6%
274
+20%
289
+6%
348
+20%
407
+17%
439
+8%
442
+1%
Shares Outstanding
Common Shares Outstanding
44
44
40
42
42
43
43
40
62
63
63
63
63
63
63
63
63
61
62
62
62
62
62
63

See Also

Summary
EUZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
EUZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EUZ stock valuation using valuation multiples.
Wall Street Estimates
EUZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EUZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.